Andersen and Berrylaw advised Delpharm on the deal. Delpharm executed the acquisition of a Poznan-based drug manufacturing plant from GSK. Delpharm is a contract drug development and...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here